Digging deep into “dirty” drugs – modulation of the methylation machinery
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Digging deep into “dirty” drugs – modulation of the methylation machinery
Authors
Keywords
-
Journal
DRUG METABOLISM REVIEWS
Volume 47, Issue 2, Pages 252-279
Publisher
Informa UK Limited
Online
2015-01-08
DOI
10.3109/03602532.2014.995379
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AID downregulation is a novel function of the DNMT inhibitor 5-aza-deoxycytidine
- (2015) Chiou-Tsun Tsai et al. Oncotarget
- The Oncogenic Polycomb Histone Methyltransferase EZH2Methylates Lysine 120 on Histone H2B and Competes Ubiquitination
- (2015) Masaharu Kogure et al. NEOPLASIA
- Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group
- (2014) Lisa Pleyer et al. ANNALS OF HEMATOLOGY
- How many JAK inhibitors in myelofibrosis?
- (2014) Bruna Velosa Ferreira et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes
- (2014) D. R. Pattabiraman et al. BLOOD
- Loss of imprinting at the 14q32 domain is associated with microRNA overexpression in acute promyelocytic leukemia
- (2014) Floriana Manodoro et al. BLOOD
- shRNA screening identifies JMJD1C as being required for leukemia maintenance
- (2014) P. Sroczynska et al. BLOOD
- How I treat myelofibrosis
- (2014) F. Cervantes BLOOD
- CpG island methylator phenotype of myelodysplastic syndrome identified through genome-wide profiling of DNA methylation and gene expression
- (2014) Xiaoli Zhao et al. BRITISH JOURNAL OF HAEMATOLOGY
- MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia
- (2014) Chong Chen et al. CANCER CELL
- The role of 5-hydroxymethylcytosine in human cancer
- (2014) Gerd P. Pfeifer et al. CELL AND TISSUE RESEARCH
- BRD4: A BET(ter) target for the treatment of AML?
- (2014) Peter Valent et al. CELL CYCLE
- Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated byDNMT3Amutational status and associated with predominant hypomethylation of HOX genes
- (2014) Ying Qu et al. Epigenetics
- Genome-wide miRNA profiling in myelodysplastic syndrome with del(5q) treated with lenalidomide
- (2014) Michaela Dostalova Merkerova et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Janus kinase inhibitors for the treatment of myeloproliferative neoplasms
- (2014) Allison Rosenthal et al. EXPERT OPINION ON PHARMACOTHERAPY
- Age-related epigenetic drift in the pathogenesis of MDS and AML
- (2014) S. Maegawa et al. GENOME RESEARCH
- Why methylation is not a marker predictive of response to hypomethylating agents
- (2014) M. T. Voso et al. HAEMATOLOGICA
- Somatic mutations of calreticulin in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms
- (2014) L. Malcovati et al. HAEMATOLOGICA
- Biochemical, Cellular, and Biophysical Characterization of a Potent Inhibitor of Mutant Isocitrate Dehydrogenase IDH1
- (2014) Mindy I. Davis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- HSC commitment–associated epigenetic signature is prognostic in acute myeloid leukemia
- (2014) Boris Bartholdy et al. JOURNAL OF CLINICAL INVESTIGATION
- Design, Synthesis, and Pharmacological Evaluation of Fluorinated Tetrahydrouridine Derivatives as Inhibitors of Cytidine Deaminase
- (2014) Dana Ferraris et al. JOURNAL OF MEDICINAL CHEMISTRY
- Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells
- (2014) W Fiskus et al. LEUKEMIA
- ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients
- (2014) M M Patnaik et al. LEUKEMIA
- Azacitidine in CMML: Matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival
- (2014) Lisa Pleyer et al. LEUKEMIA RESEARCH
- miR-125a regulates cell cycle, proliferation, and apoptosis by targeting the ErbB pathway in acute myeloid leukemia
- (2014) Melanie L. Ufkin et al. LEUKEMIA RESEARCH
- CTCF Controls HOXA Cluster Silencing and Mediates PRC2-Repressive Higher-Order Chromatin Structure in NT2/D1 Cells
- (2014) M. Xu et al. MOLECULAR AND CELLULAR BIOLOGY
- Highly Active Combination of BRD4 Antagonist and Histone Deacetylase Inhibitor against Human Acute Myelogenous Leukemia Cells
- (2014) W. Fiskus et al. MOLECULAR CANCER THERAPEUTICS
- BET Protein Antagonist JQ1 Is Synergistically Lethal with FLT3 Tyrosine Kinase Inhibitor (TKI) and Overcomes Resistance to FLT3-TKI in AML Cells Expressing FLT-ITD
- (2014) W. Fiskus et al. MOLECULAR CANCER THERAPEUTICS
- Targeting tumour-supportive cellular machineries in anticancer drug development
- (2014) Matthias Dobbelstein et al. NATURE REVIEWS DRUG DISCOVERY
- Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
- (2014) Katrina J. Falkenberg et al. NATURE REVIEWS DRUG DISCOVERY
- TET1 is a maintenance DNA demethylase that prevents methylation spreading in differentiated cells
- (2014) C. Jin et al. NUCLEIC ACIDS RESEARCH
- Methylation and miRNA Effects of Resveratrol on Mammary Tumors vs. Normal Tissue
- (2014) Wenyi Qin et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets
- (2014) R Su et al. ONCOGENE
- Overexpression of miR-125a in Myelodysplastic Syndrome CD34+ Cells Modulates NF-κB Activation and Enhances Erythroid Differentiation Arrest
- (2014) Irene Gañán-Gómez et al. PLoS One
- DOT1L Inhibition Sensitizes MLL-Rearranged AML to Chemotherapy
- (2014) Wei Liu et al. PLoS One
- Identification of circulating microRNAs as biomarkers in diagnosis of hematologic cancers: a meta-analysis
- (2014) Quan Li et al. TUMOR BIOLOGY
- Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformation
- (2014) Goro Sashida et al. Nature Communications
- Chromatin Loops as Allosteric Modulators of Enhancer-Promoter Interactions
- (2014) Boryana Doyle et al. PLoS Computational Biology
- Depletion of the Chromatin Looping Proteins CTCF and Cohesin Causes Chromatin Compaction: Insight into Chromatin Folding by Polymer Modelling
- (2014) Mariliis Tark-Dame et al. PLoS Computational Biology
- Epigenetic therapy of acute myeloid leukemia using 5-aza-2'-deoxycytidine (decitabine) in combination with inhibitors of histone methylation and deacetylation
- (2014) Richard L Momparler et al. Clinical Epigenetics
- Comparison of 7-day azacitidine and 5-day decitabine for treating myelodysplastic syndrome
- (2013) Je-Hwan Lee et al. ANNALS OF HEMATOLOGY
- Increasing role of UHRF1 in the reading and inheritance of the epigenetic code as well as in tumorogenesis
- (2013) Christian Bronner et al. BIOCHEMICAL PHARMACOLOGY
- Atypical Protein Kinase Cι as a human oncogene and therapeutic target
- (2013) Peter J. Parker et al. BIOCHEMICAL PHARMACOLOGY
- Methylation kinetics and CpG-island methylator phenotyope status in colorectal cancer cell lines
- (2013) Dominik Wodarz et al. Biology Direct
- Potent inhibition of DOT1L as treatment of MLL-fusion leukemia
- (2013) S. R. Daigle et al. BLOOD
- Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l
- (2013) A. J. Deshpande et al. BLOOD
- Targeting IDH: the next big thing in AML
- (2013) M. Levis BLOOD
- Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia
- (2013) O. Abdel-Wahab et al. BLOOD
- Tyrosine kinase inhibitors impair B-cell immune responses in CML through off-target inhibition of kinases important for cell signaling
- (2013) H. de Lavallade et al. BLOOD
- Genomic impact of transient low-dose decitabine treatment on primary AML cells
- (2013) J. M. Klco et al. BLOOD
- Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML
- (2013) A. Chaturvedi et al. BLOOD
- Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implications
- (2013) F. Thol et al. BLOOD
- Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice
- (2013) J. Wang et al. BLOOD
- Methylation-Dependent and -Independent Genomic Targeting Principles of the MBD Protein Family
- (2013) Tuncay Baubec et al. CELL
- Transcription Factor Binding in Human Cells Occurs in Dense Clusters Formed around Cohesin Anchor Sites
- (2013) Jian Yan et al. CELL
- The role, mechanism and potentially therapeutic application of microRNA-29 family in acute myeloid leukemia
- (2013) J-N Gong et al. CELL DEATH AND DIFFERENTIATION
- Epigenetically induced changes in nuclear textural patterns and gelatinase expression in human fibrosarcoma cells
- (2013) M. Poplineau et al. CELL PROLIFERATION
- Increased CDA Expression/Activity in Males Contributes to Decreased Cytidine Analog Half-Life and Likely Contributes to Worse Outcomes with 5-Azacytidine or Decitabine Therapy
- (2013) R. Z. Mahfouz et al. CLINICAL CANCER RESEARCH
- Epigenetics in focus: Pathogenesis of myelodysplastic syndromes and the role of hypomethylating agents
- (2013) Valeria Santini et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The role of epigenetics in the regulation of apoptosis in myelodysplastic syndromes and acute myeloid leukemia
- (2013) Heidrun Karlic et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The histone H3-K27 demethylase Utx regulates HOX gene expression in Drosophila in a temporally restricted manner
- (2013) O. Copur et al. DEVELOPMENT
- Epigenetic alterations and microRNAs
- (2013) Diamantina Vasilatou et al. Epigenetics
- SIR–nucleosome interactions: Structure–function relationships in yeast silent chromatin
- (2013) Mariano Oppikofer et al. GENE
- Expression of DNA Methyltransferases in Breast Cancer Patients and to Analyze the Effect of Natural Compounds on DNA Methyltransferases and Associated Proteins
- (2013) Sameer Mirza et al. Journal of Breast Cancer
- Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutations
- (2013) Daichi Inoue et al. JOURNAL OF CLINICAL INVESTIGATION
- Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
- (2013) Raphaël Itzykson et al. JOURNAL OF CLINICAL ONCOLOGY
- Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo
- (2013) Omar Abdel-Wahab et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Azacitidine in patients with WHO-defined AML – Results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group
- (2013) Lisa Pleyer et al. Journal of Hematology & Oncology
- Quantitative Analysis of Histone Demethylase Probes Using Fluorescence Polarization
- (2013) Wenqing Xu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Quantitative determination of azacitidine triphosphate in peripheral blood mononuclear cells using liquid chromatography coupled with high-resolution mass spectrometry
- (2013) Ellen J.B. Derissen et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms
- (2013) F Traina et al. LEUKEMIA
- Genome-wide profiling reveals epigenetic inactivation of the PU.1 pathway by histone H3 lysine 27 trimethylation in cytogenetically normal myelodysplastic syndrome
- (2013) J X Cheng et al. LEUKEMIA
- Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine
- (2013) A Valencia et al. LEUKEMIA
- Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia
- (2013) M A Dawson et al. LEUKEMIA
- Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes
- (2013) M M Patnaik et al. LEUKEMIA
- Epigenetics of myelodysplastic syndromes
- (2013) R Itzykson et al. LEUKEMIA
- ASXL1mutations are infrequent in young patients with primary acute myeloid leukemia and their detection has a limited role in therapeutic risk stratification
- (2013) Dima El-Sharkawi et al. LEUKEMIA & LYMPHOMA
- Decreased 5-hydroxymethylcytosine levels are associated with TET2 mutation and unfavorable overall survival in myelodysplastic syndromes
- (2013) Xiaoliu Liu et al. LEUKEMIA & LYMPHOMA
- Long range epigenetic silencing is a trans-species mechanism that results in cancer specific deregulation by overriding the chromatin domains of normal cells
- (2013) Marta Forn et al. Molecular Oncology
- Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms
- (2013) Ayana Kon et al. NATURE GENETICS
- Chromatin and epigenetic features of long-range gene regulation
- (2013) N. Harmston et al. NUCLEIC ACIDS RESEARCH
- Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice
- (2013) P Basova et al. ONCOGENE
- EZH2 Mutations Are Related to Low Blast Percentage in Bone Marrow and -7/del(7q) in De Novo Acute Myeloid Leukemia
- (2013) Xiuli Wang et al. PLoS One
- Prolonged Treatment with DNMT Inhibitors Induces Distinct Effects in Promoters and Gene-Bodies
- (2013) Yan-Fung Wong et al. PLoS One
- Cell Cycle-Dependent Turnover of 5-Hydroxymethyl Cytosine in Mouse Embryonic Stem Cells
- (2013) Junji Otani et al. PLoS One
- Single-Cell DNA-Methylation Analysis Reveals Epigenetic Chimerism in Preimplantation Embryos
- (2013) C. Lorthongpanich et al. SCIENCE
- Role of DNA Methylation in the Pathogenesis and Treatment of Myelodysplastic Syndromes
- (2013) Hina Khan et al. SEMINARS IN HEMATOLOGY
- Perturbations of 5-Hydroxymethylcytosine Patterning in Hematologic Malignancies
- (2013) Jozef Madzo et al. SEMINARS IN HEMATOLOGY
- Pharmacokinetic and pharmacodynamic analysis of 5-aza-2’-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy
- (2013) Metin Karahoca et al. Clinical Epigenetics
- BRD4 associates with p53 in DNMT3A-mutated leukemia cells and is implicated in apoptosis by the bromodomain inhibitor JQ1
- (2013) Helen Jayne Susan Stewart et al. Cancer Medicine
- Can we improve outcomes in patients with acute myelogenous leukemia? Incorporating HDAC inhibitors into front-line therapy
- (2012) Guillermo Garcia-Manero BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- The differentiating and apoptotic effects of 2-aza-5′-deoxycytidine are dependent on the PU.1 expression level in PU.1-transgenic K562 cells
- (2012) Sayuri Aoyama et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- DCK is frequently inactivated in acquired gemcitabine-resistant human cancer cells
- (2012) Yuriko Saiki et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia
- (2012) A. F. T. Ribeiro et al. BLOOD
- RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia
- (2012) J. Aimiuwu et al. BLOOD
- Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia
- (2012) S. Tanaka et al. BLOOD
- Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemia
- (2012) P. Yan et al. BLOOD
- Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression
- (2012) G. Zardo et al. BLOOD
- Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicing
- (2012) A. Dolnik et al. BLOOD
- ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression
- (2012) Omar Abdel-Wahab et al. CANCER CELL
- Decitabine triphosphate levels in peripheral blood mononuclear cells from patients receiving prolonged low-dose decitabine administration: a pilot study
- (2012) Robert S. Jansen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- DNA Methylation Does Not Stably Lock Gene Expression but Instead Serves as a Molecular Mark for Gene Silencing Memory
- (2012) N. J.- M. Raynal et al. CANCER RESEARCH
- Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
- (2012) Panagis Filippakopoulos et al. CELL
- The Prdm family: expanding roles in stem cells and development
- (2012) T. Hohenauer et al. DEVELOPMENT
- Effects ofTET2mutations on DNA methylation in chronic myelomonocytic leukemia
- (2012) Jumpei Yamazaki et al. Epigenetics
- The epigenome of AML stem and progenitor cells
- (2012) Jumpei Yamazaki et al. Epigenetics
- Higher-order orchestration of hematopoiesis: Is cohesin a new player?
- (2012) Anil K. Panigrahi et al. EXPERIMENTAL HEMATOLOGY
- Inhibition of -KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors
- (2012) M. Xiao et al. GENES & DEVELOPMENT
- A critical appraisal of tools available for monitoring epigenetic changes in clinical samples from patients with myeloid malignancies
- (2012) K. Gronbaek et al. HAEMATOLOGICA
- Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients
- (2012) C. Santamaria et al. HAEMATOLOGICA
- Mutations in epigenetic regulators in myelodysplastic syndromes
- (2012) Gorica Nikoloski et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
- (2012) Hagop M. Kantarjian et al. JOURNAL OF CLINICAL ONCOLOGY
- 5-Azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity
- (2012) N Curik et al. LEUKEMIA
- The role of HOX genes in normal hematopoiesis and acute leukemia
- (2012) R A Alharbi et al. LEUKEMIA
- Synergistic antileukemic action of a combination of inhibitors of DNA methylation and histone methylation
- (2012) Richard L. Momparler et al. LEUKEMIA RESEARCH
- Decitabine induces very early in vivo DNA methylation changes in blasts from patients with acute myeloid leukemia
- (2012) Rainer Claus et al. LEUKEMIA RESEARCH
- TET2, ASXL1 and EZH2 mutations in Chinese with myelodysplastic syndromes
- (2012) Jieyu Wang et al. LEUKEMIA RESEARCH
- EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
- (2012) Michael T. McCabe et al. NATURE
- Epizyme–Celgene deal signals interest in new class of epigenetic drugs
- (2012) Alexandra Flemming NATURE REVIEWS DRUG DISCOVERY
- Protein kinase C, an elusive therapeutic target?
- (2012) Daria Mochly-Rosen et al. NATURE REVIEWS DRUG DISCOVERY
- Role of Human Nucleoside Transporters in the Uptake and Cytotoxicity of Azacitidine and Decitabine
- (2012) Vijaya L. Damaraju et al. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- The epigenetic regulator UHRF1 promotes ubiquitination-mediated degradation of the tumor-suppressor protein promyelocytic leukemia protein
- (2012) D Guan et al. ONCOGENE
- Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways
- (2012) A R Dallosso et al. ONCOGENE
- Genome Wide Analysis of Acute Myeloid Leukemia Reveal Leukemia Specific Methylome and Subtype Specific Hypomethylation of Repeats
- (2012) Marwa H. Saied et al. PLoS One
- Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation
- (2012) W. Qi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The role of histone methyltransferase EZH2 in myelodysplastic syndromes
- (2012) Feng Xu et al. Expert Review of Hematology
- Ectopic expression of the histone methyltransferase Ezh2 in haematopoietic stem cells causes myeloproliferative disease
- (2012) A. Herrera-Merchan et al. Nature Communications
- Gene Reactivation by 5-Aza-2′-Deoxycytidine–Induced Demethylation Requires SRCAP–Mediated H2A.Z Insertion to Establish Nucleosome Depleted Regions
- (2012) Xiaojing Yang et al. PLoS Genetics
- Inhibition of cancer cell proliferation by 5-fluoro-2'-deoxycytidine, a DNA methylation inhibitor, through activation of DNA damage response pathway
- (2012) Quanyi Zhao et al. SpringerPlus
- Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies
- (2011) Ana Puda et al. AMERICAN JOURNAL OF HEMATOLOGY
- PRDM proteins: Important players in differentiation and disease
- (2011) Cathrine K. Fog et al. BIOESSAYS
- The prognostic significance of IDH2 mutations in AML depends on the location of the mutation
- (2011) C. L. Green et al. BLOOD
- Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial
- (2011) T. Braun et al. BLOOD
- ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category
- (2011) K. H. Metzeler et al. BLOOD
- Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasms
- (2011) J. Score et al. BLOOD
- The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML
- (2011) J. Zhou et al. BLOOD
- Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies
- (2011) Z. Li et al. BLOOD
- PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies
- (2011) Francois P. Duhoux et al. BRITISH JOURNAL OF HAEMATOLOGY
- Identification of a risk dependent microRNA expression signature in myelodysplastic syndromes
- (2011) Lubomir Sokol et al. BRITISH JOURNAL OF HAEMATOLOGY
- Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
- (2011) Scott R. Daigle et al. CANCER CELL
- Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid Transformation
- (2011) Kelly Moran-Crusio et al. CANCER CELL
- 5-Hydroxymethylcytosine Is Strongly Depleted in Human Cancers but Its Levels Do Not Correlate with IDH1 Mutations
- (2011) S.-G. Jin et al. CANCER RESEARCH
- Mbd3/NURD Complex Regulates Expression of 5-Hydroxymethylcytosine Marked Genes in Embryonic Stem Cells
- (2011) Ozlem Yildirim et al. CELL
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
- (2011) Rasheduzzaman Chowdhury et al. EMBO REPORTS
- Dynamics of bivalent chromatin domains upon drug induced reactivation and resilencing in cancer cells
- (2011) Regina Mayor et al. Epigenetics
- 2´-deoxy-5,6-dihydro-5-azacytidine - a less toxic alternative of 2´-deoxy-5-azacytidine
- (2011) Marika Matoušová et al. Epigenetics
- Diagnostic microRNAs in myelodysplastic syndrome
- (2011) Begum Erdogan et al. EXPERIMENTAL HEMATOLOGY
- Myelodysplastic Syndrome and Histone Deacetylase Inhibitors: “To Be or Not to Be Acetylated”?
- (2011) Sebastian Stintzing et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Prognostic Significance of ASXL1 Mutations in Patients With Myelodysplastic Syndromes
- (2011) Felicitas Thol et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of Oral Azacitidine in Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia
- (2011) Guillermo Garcia-Manero et al. JOURNAL OF CLINICAL ONCOLOGY
- Incidence and Prognostic Influence of DNMT3A Mutations in Acute Myeloid Leukemia
- (2011) Felicitas Thol et al. JOURNAL OF CLINICAL ONCOLOGY
- TET2Mutations Improve the New European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
- (2011) Klaus H. Metzeler et al. JOURNAL OF CLINICAL ONCOLOGY
- A Selective Inhibitor and Probe of the Cellular Functions of Jumonji C Domain-Containing Histone Demethylases
- (2011) Xuelai Luo et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance
- (2011) V Grossmann et al. LEUKEMIA
- Differential prognostic effect of IDH1 versus IDH2 mutations in myelodysplastic syndromes: a Mayo Clinic Study of 277 patients
- (2011) M M Patnaik et al. LEUKEMIA
- Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-Azacytidine
- (2011) M T Voso et al. LEUKEMIA
- Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms
- (2011) O Abdel-Wahab et al. LEUKEMIA
- Recurrent DNMT3A mutations in patients with myelodysplastic syndromes
- (2011) M J Walter et al. LEUKEMIA
- Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias
- (2011) R Itzykson et al. LEUKEMIA
- JmjC-domain containing histone demethylase 1B-mediatedp15Ink4bsuppression promotes the proliferation of leukemic progenitor cells through modulation of cell cycle progression in acute myeloid leukemia
- (2011) Satoki Nakamura et al. MOLECULAR CARCINOGENESIS
- Anti-proliferative effect of curcumin on melanoma cells is mediated by PDE1A inhibition that regulates the epigenetic integrator UHRF1
- (2011) Abdurazzag Abusnina et al. MOLECULAR NUTRITION & FOOD RESEARCH
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
- (2011) Johannes Zuber et al. NATURE
- The Polycomb complex PRC2 and its mark in life
- (2011) Raphaël Margueron et al. NATURE
- Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells
- (2011) William A. Pastor et al. NATURE
- Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia
- (2011) Xiao-Jing Yan et al. NATURE GENETICS
- Clinical Effect of Point Mutations in Myelodysplastic Syndromes
- (2011) Rafael Bejar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting activation-induced cytidine deaminase prevents colon cancer development despite persistent colonic inflammation
- (2011) A Takai et al. ONCOGENE
- Mechanisms of Resistance to Decitabine in the Myelodysplastic Syndrome
- (2011) Taichun Qin et al. PLoS One
- Targeting MYC dependence in cancer by inhibiting BET bromodomains
- (2011) J. A. Mertz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Stability of 5-Fluoro-2′-deoxycytidine and Tetrahydrouridine in Combination
- (2010) Duoli Guo et al. AAPS PHARMSCITECH
- Overexpression of the EZH2, RING1 and BMI1 genes is common in myelodysplastic syndromes: relation to adverse epigenetic alteration and poor prognostic scoring
- (2010) Feng Xu et al. ANNALS OF HEMATOLOGY
- The prognostic significance of IDH1 mutations in younger adult patients with acute myeloid leukemia is dependent on FLT3/ITD status
- (2010) C. L. Green et al. BLOOD
- Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia
- (2010) C. Muller-Tidow et al. BLOOD
- Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists
- (2010) David Mossman et al. BMC CANCER
- Prolonged responses in patients with MDS and CMML treated with azacitidine and etanercept
- (2010) Bart L. Scott et al. BRITISH JOURNAL OF HAEMATOLOGY
- Mechanisms of leukemogenesis by MLL fusion proteins
- (2010) Rolf Marschalek BRITISH JOURNAL OF HAEMATOLOGY
- Anti-thymocyte globulin plus etanercept as therapy for myelodysplastic syndromes (MDS): a phase II study
- (2010) Bart L. Scott et al. BRITISH JOURNAL OF HAEMATOLOGY
- The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
- (2010) Patrick S. Ward et al. CANCER CELL
- DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia
- (2010) Maria E. Figueroa et al. CANCER CELL
- Impact of TET2 mutations on mRNA expression and clinical outcomes in MDS patients treated with DNA methyltransferase inhibitors
- (2010) Daniel A. Pollyea et al. HEMATOLOGICAL ONCOLOGY
- Epigenetic Changes in the Myelodysplastic Syndrome
- (2010) Jean-Pierre Issa HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Predictors of global methylation levels in blood DNA of healthy subjects: a combined analysis
- (2010) Zhong-Zheng Zhu et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- IDH1andIDH2Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
- (2010) Guido Marcucci et al. JOURNAL OF CLINICAL ONCOLOGY
- Deoxycytidine kinase is downregulated in Ara-C-resistant acute myeloid leukemia murine cell lines
- (2010) S K Rathe et al. LEUKEMIA
- Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia
- (2010) J Boultwood et al. LEUKEMIA
- Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome and acute myeloid leukemia
- (2010) A Quintás-Cardama et al. LEUKEMIA
- Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
- (2010) Myunggon Ko et al. NATURE
- Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine
- (2010) Chun-Xiao Song et al. NATURE BIOTECHNOLOGY
- Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes
- (2010) Gorica Nikoloski et al. NATURE GENETICS
- Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
- (2010) Ryan D Morin et al. NATURE GENETICS
- DNMT3AMutations in Acute Myeloid Leukemia
- (2010) Timothy J. Ley et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines
- (2010) Paul W. Hollenbach et al. PLoS One
- Methylation and silencing of miRNA-124 by EVI1 and self-renewal exhaustion of hematopoietic stem cells in murine myelodysplastic syndrome
- (2010) J. Dickstein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Protein Kinase C Agonist PEP005 (Ingenol 3-Angelate) in the Treatment of Human Cancer: A Balance between Efficacy and Toxicity
- (2010) Elisabeth Ersvaer et al. Toxins
- Drug discovery targeting epigenetic codes: The great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis
- (2009) Motoko Unoki et al. BIOCHEMICAL PHARMACOLOGY
- Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies
- (2009) O. Abdel-Wahab et al. BLOOD
- Heterozygous deletion of the PU.1 locus in human AML
- (2009) N. Bonadies et al. BLOOD
- Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells
- (2009) W. Fiskus et al. BLOOD
- MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1
- (2009) R. Garzon et al. BLOOD
- TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)
- (2009) O. Kosmider et al. BLOOD
- Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies
- (2009) T. E. Fandy et al. BLOOD
- MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation
- (2009) M. E. Figueroa et al. BLOOD
- The protein kinase C agonist PEP005 increases NF-κB expression, induces differentiation and increases constitutive chemokine release by primary acute myeloid leukaemia cells
- (2009) Astrid Marta Olsnes et al. BRITISH JOURNAL OF HAEMATOLOGY
- Cancer DNA Methylation: Molecular Mechanisms and Clinical Implications
- (2009) M. T. McCabe et al. CLINICAL CANCER RESEARCH
- The role of microRNAs in normal and malignant hematopoiesis
- (2009) Diamantina Vasilatou et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Decitabine versus 5-azacitidine for the treatment of myelodysplastic syndrome: adjusted indirect meta-analysis
- (2009) A. Kumar et al. HAEMATOLOGICA
- TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia
- (2009) O. Kosmider et al. HAEMATOLOGICA
- 5-azacitidine prolongs overall survival in patients with myelodysplastic syndrome - a systematic review and meta-analysis
- (2009) R. Gurion et al. HAEMATOLOGICA
- Interplay between DNA methylation, histone modification and chromatin remodeling in stem cells and during development
- (2009) Kohta Ikegami et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Simultaneous analysis of eight nucleoside triphosphates in cell lines by liquid chromatography coupled with tandem mass spectrometry
- (2009) Sabine Cohen et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- DNA Methylation Predicts Survival and Response to Therapy in Patients With Myelodysplastic Syndromes
- (2009) Lanlan Shen et al. JOURNAL OF CLINICAL ONCOLOGY
- Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
- (2009) Pierre Fenaux et al. JOURNAL OF CLINICAL ONCOLOGY
- Toxoplasma H2A Variants Reveal Novel Insights into Nucleosome Composition and Functions for this Histone Family
- (2009) Maria C. Dalmasso et al. JOURNAL OF MOLECULAR BIOLOGY
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
- (2009) Pierre Fenaux et al. LANCET ONCOLOGY
- The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells
- (2009) C Flotho et al. LEUKEMIA
- Human concentrative nucleoside transporter 1-mediated uptake of 5-azacytidine enhances DNA demethylation
- (2009) M. Rius et al. MOLECULAR CANCER THERAPEUTICS
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
- (2009) Lenny Dang et al. NATURE
- Protein methyltransferases as a target class for drug discovery
- (2009) Robert A. Copeland et al. NATURE REVIEWS DRUG DISCOVERY
- Linking DNA methylation and histone modification: patterns and paradigms
- (2009) Howard Cedar et al. NATURE REVIEWS GENETICS
- Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome
- (2009) Elaine R. Mardis et al. NEW ENGLAND JOURNAL OF MEDICINE
- The multi-domain protein Np95 connects DNA methylation and histone modification
- (2009) Andrea Rottach et al. NUCLEIC ACIDS RESEARCH
- Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
- (2009) M. Tahiliani et al. SCIENCE
- Azacitidine: activity and efficacy as an epigenetic treatment of myelodysplastic syndromes
- (2009) Valeria Santini Expert Review of Hematology
- Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse
- (2008) H. Kroeger et al. BLOOD
- Mechanisms of resistance to 5-aza-2'-deoxycytidine in human cancer cell lines
- (2008) T. Qin et al. BLOOD
- MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia
- (2008) M. Jongen-Lavrencic et al. BLOOD
- Aberrant DNA methylation is a dominant mechanism in MDS progression to AML
- (2008) Y. Jiang et al. BLOOD
- Proteins that bind methylated DNA and human cancer: reading the wrong words
- (2008) L Lopez-Serra et al. BRITISH JOURNAL OF CANCER
- H3K79 Methylation Profiles Define Murine and Human MLL-AF4 Leukemias
- (2008) Andrei V. Krivtsov et al. CANCER CELL
- Results of combination therapy with amifostine, pentoxifylline, ciprofloxacin and dexamethasone in patients with myelodysplastic syndrome and acute myeloid leukemia
- (2008) Alev Akyol Erikci et al. Hematology
- Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine
- (2008) Carlo Stresemann et al. INTERNATIONAL JOURNAL OF CANCER
- Response to the Methylation Inhibitor Dihydro-5-azacytidine in Mesothelioma Is Not Associated with Methylation of p16INK4a: Results of Cancer and Leukemia Group B 159904
- (2008) Robert A. Kratzke et al. Journal of Thoracic Oncology
- Global increase in DNA methylation in patients with myelodysplastic syndrome
- (2008) D Römermann et al. LEUKEMIA
- Protein kinase C signalling in leukemia
- (2008) Amanda J. Redig et al. LEUKEMIA & LYMPHOMA
- Methyltransferases in myelodysplastic syndromes: Guilty or not guilty?
- (2008) Bruno Quesnel LEUKEMIA RESEARCH
- Aberrant promotor methylation in MDS hematopoietic cells during in vitro lineage specific differentiation is differently associated with DNMT isoforms
- (2008) Olaf Hopfer et al. LEUKEMIA RESEARCH
- The CpG Island Methylator Phenotype Correlates with Long-Range Epigenetic Silencing in Colorectal Cancer
- (2008) P. Karpinski et al. MOLECULAR CANCER RESEARCH
- Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer
- (2008) S. Varambally et al. SCIENCE
- The Insulator Binding Protein CTCF Positions 20 Nucleosomes around Its Binding Sites across the Human Genome
- (2008) Yutao Fu et al. PLoS Genetics
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now